-
Nov 2008
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Nov 2008
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses.
J ImmunolZhou B, Headley MB, Aye T, Tocker J, Comeau MR, Ziegler SF -
Nov 2008
Functional analysis of FOXP3.
Ann N Y Acad SciBuckner JH, Ziegler SF -
Oct 2008
Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor.
J ImmunolLee HC, Headley MB, Iseki M, Ikuta K, Ziegler SF -
Oct 2008
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity.
DiabetologiaMartin-Pagola A, Sisino G, Allende G, Dominguez-Bendala J, Gianani R, Reijonen H, Nepom GT, Ricordi C, Ruiz P, Sageshima J, Ciancio G, Burke GW, Pugliese A -
Oct 2008
Approaching the Heisenberg principle of immunology.
Clin ImmunolNepom GT -
Oct 2008
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Diabetes CareGreenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research Group., European C-Peptide Trial Study Group. -
Oct 2008
The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.
Infect ImmunKwok WW, Yang J, James EA, Bui J, Huston L, Wiesen AR, Roti M -
Sep 2008
Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response.
J ImmunolJessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BR, Ziegler SF, Comeau MR -
Aug 2008
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.
Proc Natl Acad Sci U S AHe R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS -
Aug 2008
Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.
Hum ImmunolKlucar P, Barnes PF, Kong Y, Samten B, Tvinnereim A, Spallek R, Nepom GT, Singh M, Shams H -
Aug 2008
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
J AutoimmunYang J, Danke N, Roti M, Huston L, Greenbaum CJ, Pihoker C , James EA, Kwok WW -
Aug 2008
Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.
Mt Sinai J MedBollyky J, Sanda S, Greenbaum CJ -
Jul 2008
Regulatory T cells and inflammation: better late than never.
ImmunityZiegler SF -
Jul 2008
Foxp3+ regulatory T cells maintain immune homeostasis in the skin.
J Exp MedDudda JC, Perdue N, Bachtanian E, Campbell DJ
